Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    21481640 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
Phase II Study of Florbetaben (BAY 94-9172) PET Imaging for Detection/Exclusion of Cerebral β-amyloid in Patients With Probable Alzheimer's Disease Compared to Healthy Volunteers
Conditions: Alzheimer Disease;   Amyloid Beta-Protein
Intervention: Drug: Florbetaben (BAY94-9172)

Indicates status has not been verified in more than two years